1. Home
  2. CORT vs FULT Comparison

CORT vs FULT Comparison

Compare CORT & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • FULT
  • Stock Information
  • Founded
  • CORT 1998
  • FULT 1882
  • Country
  • CORT United States
  • FULT United States
  • Employees
  • CORT N/A
  • FULT N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • FULT Major Banks
  • Sector
  • CORT Health Care
  • FULT Finance
  • Exchange
  • CORT Nasdaq
  • FULT Nasdaq
  • Market Cap
  • CORT 7.5B
  • FULT 3.4B
  • IPO Year
  • CORT N/A
  • FULT N/A
  • Fundamental
  • Price
  • CORT $71.41
  • FULT $19.16
  • Analyst Decision
  • CORT Strong Buy
  • FULT Hold
  • Analyst Count
  • CORT 4
  • FULT 3
  • Target Price
  • CORT $142.00
  • FULT $19.33
  • AVG Volume (30 Days)
  • CORT 1.5M
  • FULT 1.6M
  • Earning Date
  • CORT 07-28-2025
  • FULT 07-15-2025
  • Dividend Yield
  • CORT N/A
  • FULT 3.76%
  • EPS Growth
  • CORT 8.36
  • FULT 5.42
  • EPS
  • CORT 1.14
  • FULT 1.70
  • Revenue
  • CORT $685,446,000.00
  • FULT $1,199,059,000.00
  • Revenue This Year
  • CORT $35.83
  • FULT N/A
  • Revenue Next Year
  • CORT $35.24
  • FULT $4.30
  • P/E Ratio
  • CORT $62.48
  • FULT $11.29
  • Revenue Growth
  • CORT 30.93
  • FULT 15.48
  • 52 Week Low
  • CORT $31.46
  • FULT $14.33
  • 52 Week High
  • CORT $117.33
  • FULT $22.49
  • Technical
  • Relative Strength Index (RSI)
  • CORT 49.05
  • FULT 61.39
  • Support Level
  • CORT $70.09
  • FULT $19.04
  • Resistance Level
  • CORT $73.44
  • FULT $19.57
  • Average True Range (ATR)
  • CORT 2.64
  • FULT 0.43
  • MACD
  • CORT 0.04
  • FULT 0.08
  • Stochastic Oscillator
  • CORT 46.11
  • FULT 71.98

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About FULT Fulton Financial Corporation

Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.

Share on Social Networks: